Increasing Planning Efficiency in Clinical Development: A new research-driven white paper from ClearTrial
Under the current global operating enviroment, biopharmaceutical and medical device companies are placing more demand on their planning and forecasting processes and capabilities, and setting lower tolerances for variance between planned and actual performance.
This white paper explores current planning trends and challenges in clinical development, and presents solutions and best practices that leading companies are utilizing to increase planning efficiency. Benefits of this greater efficiency include compressed clinical study timelines, and a reduction in study costs and risks.
Download the white paper today at http://info.cleartrial.com/PharmaExec.html
|
